Restoring mitochondrial renewal may account for all lasting benefits of the tested interventions
Mitochondrial renewal in surviving cells may explain all lasting benefits of the tested interventions. Benefit from cell clearance despite selectively blocked renewal, or failure of renewal alone with senescent cells and their inflammatory secretion held near baseline, would reject the claim.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Rhythm or programme
Mitophagy
The delivery of mitochondria to lysosomes and removal of whole mitochondria
Where this hypothesis actsSurviving parenchymal cells, including cardiomyocytes and muscle fibres, during ageing
Hypotheses on this target 3
Inhibition1
Activation2
Function preservation
Feedback restoration
Rhythm restoration
Direct measurement

What is proposed
Activation
Restore mitophagy in surviving cells
With whatControlled genetic model
HowInducible genetic interventions to switch mitophagy off and restore it, with mitophagy reporters to track the response
Possible result
Possible sustained functional benefits across multiple systems and increased lifespan
From the recordВозврат митофагии восстанавливает пользу.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Several ways of slowing age-related decline could turn out to depend on the same repair process inside surviving cells. The unexpected move is to propose that even removing harmful cells works through the renewal of mitochondria in nearby heart and muscle cells, triggered by the response that engulfs and clears removed cells. This is a hypothesis generated by the pipeline, not a measured result.
- Direct restoration of mitochondrial renewal repairs the maintenance process in surviving heart and muscle cells.
- Removal of senescent cells by immune cells is proposed to trigger an engulfing-and-clearing response.
- That clearing response is proposed to activate mitochondrial renewal in neighboring surviving heart and muscle cells.
- Reducing inflammatory releases is also proposed to restore the same renewal process, although the intervening route is not specified.
- Restored mitochondrial renewal is proposed to produce lasting benefits across several body systems and extend lifespan.
- Blocking mitophagy, the selective breakdown and recycling of mitochondria, is predicted to eliminate the lasting benefits of both indirect routes; restoring it is predicted to bring those benefits back.
Three switches might appear to power three different lights, while all three actually feed the same lamp. Disconnecting that lamp would make every switch ineffective.
Where the picture breaks: Cells do not have perfectly isolated wiring. Disabling mitochondrial renewal could damage their ability to benefit from any intervention, so a shared loss of benefit would not by itself prove that every intervention works through the same route.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.
Rests on: The goal defines a potential route to life extension as a precise intervention on a cause shared by several aging processes.
Stated in the chain - Goal pillarstep 02 of 04
The desired result is a list of life-extension ideas that work through genuinely separate causes.
Rests on: The master question requests ideas for interventions on shared causes of aging; this stage specifies that the list should distinguish causally separate ideas.
Stated in the chain - Gap questionstep 03 of 04
The number of distinct ideas would be determined by separately switching intermediate biological processes off and back on, then comparing lasting benefits across several body systems and effects on lifespan.
Rests on: The preceding goal requires distinguishing ideas by their causes, but does not specify how that distinction should be measured.
AssumptionThe work adopts the assumption that dependence on separately controlled intermediate processes, judged by lasting function and lifespan, provides the relevant way to count independent ideas.
- Hypothesisstep 04 of 04
All three candidate interventions are proposed to share one sufficient route: renewing mitochondria in surviving cells. Lowering inflammatory releases from senescent cells, cells in a persistent state of stopped division, or removing those cells would provide lasting general benefits only by restoring that renewal. The proposed bridge from cell removal to renewal is the engulfing-and-clearing response in the surrounding tissue.
Rests on: The preceding question supplies the logic of switching intermediate processes off and restoring them. The endpoint fills that framework with the proposed dependence of all lasting benefits on mitochondrial renewal.
AssumptionThe central causal assumption is that mitochondrial renewal is sufficient by itself and necessary for the lasting benefits of both other interventions. The supplied material does not establish that dependence or the proposed bridge from cell clearance to renewal in neighboring heart and muscle cells; these are the claims being proposed.
What is carried, and what is not. Individual links have partial support in other settings: S5, a 2026 review in Cells, reports that restoring mitochondrial function or maintenance can improve connective-tissue-supporting cells, but does not test the proposed interventions or lasting whole-body benefits; S6, published in Aging Cell in 2026, reports that blocking mitochondrial recycling abolished protection in ultraviolet-exposed skin models, but does not establish the proposed route in heart or muscle. No supplied source establishes the full sequence or its exclusivity: S2, published in Nature Medicine in 2016, explicitly leaves other contributions to lifespan extension open, although that does not itself disprove this hypothesis.S5S6S2
Where the reasoning is carried by something unstated · 2
- Gap question. The work adopts the assumption that dependence on separately controlled intermediate processes, judged by lasting function and lifespan, provides the relevant way to count independent ideas.
- Hypothesis. The central causal assumption is that mitochondrial renewal is sufficient by itself and necessary for the lasting benefits of both other interventions. The supplied material does not establish that dependence or the proposed bridge from cell clearance to renewal in neighboring heart and muscle cells; these are the claims being proposed.
How a result here could mislead · 3
- Loss of benefit after blocking mitochondrial recycling could reflect injury to surviving cells rather than removal of the process through which the treatments work. Calling the block mild does not establish that it is harmless. What closes it: The same block must be assessed without the beneficial interventions, alongside cell health and tissue function. Its restriction to the intended surviving cells, its effect on recycling, and recovery after restoration must be verified.
- Apparent benefit from mitochondrial renewal alone could still depend on an unnoticed decrease in harmful cells or their inflammatory releases. Conversely, failure could arise from damage caused by the method used to keep those quantities at their starting levels. What closes it: Both cell numbers and inflammatory releases must be followed throughout the relevant period, with acceptable departures from starting levels fixed in advance. Controls must establish the effects of the maintenance procedure itself; the supplied design acknowledges this requirement but does not specify how to meet it.
- Dependence of cell-removal benefits on mitochondrial recycling could be mistaken for evidence that the engulfing-and-clearing response is what triggers renewal in neighboring cells. Those are separate causal claims. What closes it: Testing that bridge requires distinguishing completed cell removal from the subsequent clearing response, and measuring renewal in the proposed neighboring cells. A way to separate those events is not supplied.
What would make this wrong. The central claim would be contradicted if reducing inflammatory releases or removing senescent cells retained lasting functional and lifespan benefits despite verified, appropriately restricted suppression of mitochondrial recycling without disabling injury. It would also be contradicted if verified restoration of mitochondrial renewal alone failed to provide those benefits while harmful-cell numbers and inflammatory releases remained near their starting levels under a maintenance procedure shown not to cause the failure.
What it would change. If the predicted pattern held, the tested candidates would represent one sufficient life-extension idea, and their apparent diversity would not justify counting them as independent solutions. Work on the master question would then have to distinguish genuinely separate causes from different ways of restoring the same process. Even that result would apply only to the tested candidates and conditions; the input specifies no endpoint species, follow-up duration, or complete intervention methods, and would not establish a universal solution to aging.
Sources read · 9
The Gut-Brain-Muscle Axis: Microbial Regulation of Neuromuscular Aging and Cognitive Frailty. · Microorganisms · 2026
“We further discuss the role of exercise-induced microbiota remodeling and muscle endocrine signaling in promoting mitochondrial biogenesis and cognitive resilience.”
Does not settle: Источник не проверяет иммунное удаление клеток, фагоцитарный ответ, кардиомиоциты, минимальный достаточный набор {M} или утверждение, что восстановление митохондриального обновления объясняет все длительные эффекты R и C.
Cardioprotection and lifespan extension by the natural polyamine spermidine. · Nature medicine · 2016
“Other protective effects of spermidine (including anti-tumorigenic effects ) may also contribute to its lifespan-extending effects, although we did not detect a reduced cancer incidence in aged spermidine-treated C57BL/6 mice,”
Does not settle: The source does not establish that mitochondrial renewal is the sole durable-benefit mechanism, that immune clearance causes mitochondrial renewal in neighboring cardiomyocytes or muscle fibers, or that reducing inflammatory secretion and senescent-cell number is insufficient.
Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia. · International journal of molecular sciences · 2022
“The mammalian target of rapamycin (mTOR) is a major regulator of skeletal myocyte viability.”
Does not settle: This review excerpt does not establish that restoring mitochondrial renewal accounts for lasting benefits of any tested interventions, that it is a minimal sufficient intervention, or that immune clearance triggers mitochondrial renewal in neighboring cardiomyocytes or muscle fibers.
“Recent intervention studies further suggest that restoring mitochondrial metabolism or mitochondrial homeostasis can improve MSC function and attenuate senescence-associated phenotypes, including through the regulation of glutamine metabolism, the enhancement of mitochondrial biogenesis and the induction of mitophagy”
Does not settle: This review does not test the proposed M, R or C interventions, immune removal of cells, phagocyte-triggered mitochondrial renewal in neighboring cardiomyocytes or muscle fibers, durable whole-organism benefits, or whether mitochondrial renewal is necessary and sufficient for all benefits.
The Secretome Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Skin Photoaging by Enhancing Mitophagy to Inhibit the cGAS-STING Pathway. · Aging cell · 2026
“Importantly, these protective effects were abolished by the mitophagy inhibitor Mdivi‐1, whereas the STING inhibitor H151 effectively reversed the Mdivi‐1‐induced loss of protection, confirming that SCT acts through the hierarchical mitophagy–cGAS‐STING axis.”
Does not settle: This source studies hUC-MSC secretome treatment in UV-exposed mice and UVB-irradiated human keratinocytes. It does not test immune clearance of senescent cells, phagocyte-triggered mitochondrial renewal in cardiomyocytes or muscle fibers, the proposed R/C interventions, lasting general benefits, or whether mitophagy alone is a minimal sufficient intervention.
Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A. · Nutrients · 2026
“Both 500 mg and 1000 mg doses significantly modulated plasma acylcarnitine profiles and induced mitochondrial gene expression in skeletal muscle biopsies, providing the first human evidence of target engagement (mitophagy pathway activation) following oral UA consumption [ ].”
Does not settle: This review does not establish that mitochondrial renewal accounts for all lasting benefits of the tested interventions, that it is the minimal sufficient intervention, or that immune clearance triggers mitochondrial renewal in neighboring cardiomyocytes or muscle fibers. It also does not test the proposed causal roles of R and C or whether reduced inflammatory secretion and senescent-cell number are insufficient on their own.
Mechanical loading primes MSC-derived exosomes to promote cartilage repair. · Bioactive materials · 2026
“Mechanistically, miR-330-3p restores mitochondrial quality control in chondrocytes by engaging an FKBP4-FoxO3a-dependent mitophagy program, leading to activation of PINK1/Parkin-mediated mitochondrial clearance.”
Does not settle: Источник описывает восстановление контроля качества митохондрий в хондроцитах и восстановление хряща в модели дефекта хряща у крыс. Он не устанавливает, что это объясняет все длительные эффекты вмешательств, не сравнивает наборы {M}, {R} и {C}, не изучает удаление сенесцентных клеток, фагоцитарный ответ, кардиомиоциты или мышечные волокна.
Juyuanjian attenuates sarcopenia through dual regulation of the Akt/FoxO1 and SIRT1/PGC-1α pathways. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
“it also upregulated the expression of SIRT1 and PGC-1α, promoting mitochondrial biogenesis and adenosine triphosphate (ATP) production.”
Does not settle: The abstract does not establish mitochondrial renewal as the sole cause of lasting benefit, a minimal sufficient intervention, or a causal role for senescent-cell removal, phagocytic responses, neighboring cardiomyocytes, or muscle fibers. It reports JYJ effects in C. elegans, C2C12 cells, and SAMP8 mice, alongside effects on protein degradation and inflammation.
Human umbilical cord-derived mesenchymal stromal cells ameliorate aging-associated skeletal muscle atrophy and dysfunction by modulating apoptosis and mitochondrial damage in SAMP10 mice. · Stem cell research & therapy · 2022
“Our results suggest that UC-MSCs can improve sarcopenia-related skeletal muscle atrophy and dysfunction via anti-apoptosis, anti-inflammatory, and mitochondrial biogenesis mechanisms that might be mediated by an AMPK-PGC1-α axis.”
Does not settle: Источник описывает лечение UC-MSC у мышей SAMP10 и не устанавливает, что восстановление митохондриального обновления является единственной причиной длительной общей пользы. Он не проверяет минимальный набор {M}, роли R и C, иммунное удаление клеток, фагоцитарный запуск обновления в соседних кардиомиоцитах или мышечных волокнах, а также недостаточность снижения воспалительной секреции и числа сенесцентных клеток.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?
Original wording · exactly as the pipeline generated it
Сколько причинно самостоятельных идей «серебряных пуль» содержит проверяемый набор мишеней, если раздельное выключение и восстановление посредников должно определить, какие воздействия остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?
What this question is asking
The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring mediators—the biological steps through which an intervention produces its effects—can distinguish interventions by their lasting benefits across several body systems and their effects on lifespan. Interventions would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared mediators and limits on the benefit available may make different interventions look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.
- Biological target
- A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
- Intervention
- A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, interventions are compared by their biological dependencies and lasting outcomes.
- Mediator and biological dependency
- A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
- Disabling and restoration
- Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
- Causally independent routes and causal equivalence
- These describe whether interventions work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
- Ceiling on benefit
- A limit beyond which a measured benefit no longer increases. Such a limit could make different interventions look similar, but its role in the intended target collection is not established.
- Muscle stem cells and activation
- Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
- Cyclin D1
- A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
- Genes and genetically altered model
- Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
- Autophagy
- A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
- Dietary restriction
- Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
- Insulin sensitivity
- How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
- Oxygen-dependent metabolism
- The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the interventions work.
- Littermates
- Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
Separate disabling and restoration of mediators can determine which interventions remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.
A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of interventions into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.
S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting cellular recycling in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6
The same question asked without the part nothing read establishes:
- Which interventions in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
- What do the read sources establish about whether the candidate interventions depend on the same biological steps for their benefits?
- Several targets reduce to fewer routes If the dependency tests showed that differently named interventions produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
- Several routes remain distinguishable If interventions retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
- The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the interventions were equivalent or whether the comparison could not distinguish them.
An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several interventions depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the interventions work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.
S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, причинные классы не подсчитаны.
Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем хроническом горизонте.
Число названных мишеней неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие посредники и насыщение могут скрывать различия.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
В наборе содержится одна самостоятельная идея: восстановление митохондриального обновления в сохраняющихся клетках. Минимальный достаточный набор воздействия состоит из одного элемента {M}; воздействия R и C дают длительную общую пользу лишь постольку, поскольку вторично восстанавливают этот же процесс. Предполагается, что после иммунного удаления клеток фагоцитарный ответ запускает обновление митохондрий в соседних кардиомиоцитах и мышечных волокнах. Уменьшение воспалительной секреции и числа сенесцентных клеток само по себе недостаточно. Пустой набор сохраняет исходную возрастную траекторию. Причинное разбиение кандидатов имеет вид {{M,R,C}}, а минимальный представитель класса имеет вид {M}.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При подтверждённом удалении сенесцентных клеток и снижении их секреции мягкое выключение митофагии только в сохраняющихся паренхиматозных клетках полностью устраняет длительную пользу C и R. Возврат митофагии восстанавливает пользу. Напротив, изолированное M сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа сенесцентных клеток и их воспалительной секреции около исходного уровня. Такой результат отличает единственный достаточный элемент {M} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.
Would tell it apart from at least one rival. The prediction specifies loss, restoration, and preservation of benefits under stated conditions, providing measurable qualitative outcomes. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Репортёры митофагии и индуцируемые генетические вмешательства позволяют проверить ближайшую причинную зависимость. Проверка достаточности при сохранении исходной секреции значительно сложнее: потребуется контролировать несколько факторов, а также исключить повреждение от самого способа их поддержания.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При подтверждённом удалении сенесцентных клеток и снижении их секреции мягкое выключение митофагии только в сохраняющихся паренхиматозных клетках полностью устраняет длительную пользу C и R. Возврат митофагии восстанавливает пользу. Напротив, изолированное M сохраняет функциональный и жизненный выигрыш при экспериментальном удержании числа сенесцентных клеток и их воспалительной секреции около исходного уровня. Такой результат отличает единственный достаточный элемент {M} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.
- Rival 01 of 03What would separate them
Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания завершённого потока митофагии R перестаёт давать дополнительный длительный эффект. C сохраняет пользу при умеренном специфическом снижении M; M сохраняет пользу при снижении C. Возврат соответствующего посредника восстанавливает только его ветвь. Изотопное отслеживание переработки материала показывает два независимо изменяемых продуктивных потока. В отличие от гипотезы 01, C способен приносить пользу при ограниченном M; в отличие от гипотезы 03, R не сохраняет отдельного эффекта при фиксированном M; в отличие от гипотезы 04, одиночные M и C проходят общий критерий успеха.
- What would separate them
Organelle upkeep, secretion control and cell removal may independently extend life predicts: Каждое одиночное воздействие проходит общий критерий успеха и сохраняет часть пользы при специфическом ограничении двух других процессов. Для C подавление представления антигенов клетками-мишенями устраняет удаление клеток и длительный эффект; возврат представления антигенов восстанавливает оба результата. M и R сохраняют пользу в тех же условиях. Особенно различающий результат: R улучшает функции и выживаемость при экспериментально фиксированных потоке митофагии и числе сенесцентных клеток.
- Rival 03 of 03What would separate them
Mitochondrial upkeep and senescent cell removal may jointly be required for longer life predicts: Из семи активных сочетаний общий критерий успеха проходят только M+C и M+R+C; добавление R к M+C не улучшает результат сверх заранее заданной границы эквивалентности. Ни M, ни C по отдельности не достигают критерия даже при подтверждённом воздействии на мишень и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. Одиночная достаточность M, ожидаемая в гипотезе 01, или самостоятельная достаточность C, ожидаемая в гипотезах 02 и 03, опровергает этот набор.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Парадоксальная опора: обслуживание митохондрий кардиомиоцитов частично выполняют соседние макрофаги. Это показывает, что клеточная граница и граница обслуживающего процесса различаются, но не доказывает предложенную универсальную зависимость. [Nicolás-Ávila и соавт., Cell, 2020](https://pubmed.ncbi.nlm.nih.gov/32937105/). В клеточной работе восстановление базальной митофагии обращало ряд признаков старения. [Исследование базальной митофагии, 2024](https://pubmed.ncbi.nlm.nih.gov/38897197/).
Геронтология сенесцентных клеток; пересмотру подлежал бы учебный раздел «Сенолитики и причинная роль накопления сенесцентных клеток». Сильное утверждение состоит в том, что весь длительный общий выигрыш исследуемых воздействий определяется митофагией сохраняющихся клеток.
Сохранение высокой сенесцентной нагрузки и воспалительной секреции совместимо с полным выигрышем M, тогда как эффективное удаление сенесцентных клеток теряет весь длительный выигрыш при избирательном нарушении митофагии соседних клеток.
Строго доказать отсутствие такой позиции во всей литературе невозможно. В выполненном целевом поиске не найден обзор, утверждающий именно полную зависимость многосистемной и жизненной пользы M, R и C от митофагии сохраняющихся клеток. Известные обзоры связи митофагии и фагоцитоза этой сильной версии не устанавливают. Статус роли HERETICAL остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.